SCHEMBL29797014

SCHEMBL29797014

CCOC(=O)Cl.NNC(=O)C1CCN(C(=O)OCc2ccccc2)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.59
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
CYP2C19 P33261 1/20 0.56
HTT P42858 2/20 0.53
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ENPP2 Q13822 1/20 0.47
GRIN2B Q13224 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
CYP2D6 P10635 2/20 0.45
CYP2C9 P11712 2/20 0.45
MAPT P10636 2/20 0.45
MMP1 P03956 1/20 0.44
MMP3 P08254 1/20 0.44
MMP7 P09237 1/20 0.44
MMP9 P14780 1/20 0.44
MMP13 P45452 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26962003 0.90 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL26962235 0.90 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL2712060 0.83 SMN1; SMN2 (0.77) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL5766528 0.81 NPC1 (0.66) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL830296 0.81 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL29854660 0.80 SMN1; SMN2 (0.71) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL4671484 0.80 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL6473595 0.80 HTT (0.67) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL24025460 0.78 HTT (0.65) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL26285480 0.78 HTT (0.65) SMN1; SMN2NPC1RAB9ACYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 EP disclosed
WO-2022171745-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2022-08-18 WO disclosed